In the News

386 News Items found
Q&A
Results to be presented at the upcoming American Society of Clinical Oncology (ASCO) meeting suggest combination immunotherapy may help more people with the most common form of lung cancer.
Advanced lung cancer patient Giancarlo Oviedo-Mori watches the sun set over the water with his 2-year-old son.
Learn how new research and clinical trials at Memorial Sloan Kettering Cancer Center (MSK) have helped 32-year-old Giancarlo Oviedo-Mori survive — and thrive — with advanced lung cancer for 15 years.
David Jones in the operating room
Learn about the goals of the Fiona and Stanley Druckenmiller Center for Lung Cancer Research: to reveal more about the biology of lung cancer, to examine novel treatment approaches, and to bring promising new therapies to our patients.
David and Margaret
For the first time, a targeted drug is showing promise at treating non-small cell lung cancer caused by a mutation called KRAS-G12D.
Khaliq Sanda
A team of doctors and researchers at MSK have identified a new, rare type of small cell lung cancer that primarily affects younger people who have never smoked. Learn how one 19-year-old patient sparked a detective story.
Physician-scientist Charles Rudin
In the Clinic
Researchers discover that a subset of lung adenocarcinomas are aggressive because of mutations that allow them to block ferroptosis, a type of cell death.
Joyce Tyson
In the Clinic
An international study led by MSK investigators has found that liquid biopsies may improve survival in people with lung cancer. These blood tests are easier for patients than more traditional tissue biopsies.
MSK medical physicist Michael Bellamy
Feature
6 Myths About Radon and Lung Cancer
Learn about the connection between radon and the risk of lung cancer.
Two cancer researchers at the American Society of Clinical Oncology annual meeting
In the News
Couldn’t be at ASCO this year? Read highlights from the first half of the meeting.
Nurse practitioner Amy Devigne
Support
An MSK program helps lung cancer survivors stay healthy following successful treatment for their disease.